ABBOTINDIA25,230.00

Abbott India Ltd.

· Pharma & Health
₹ CrorePeersPFIZERGLAXOIPCALABAJANTPHARMANTHEMMEDANTAGLENMARKBIOCON
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Non-current Assets
+ Property, Plant & Equipment218.3329.5327.5
+ Capital Work-in-Progress10.118.15.5
+ Other Intangibles6.76.53.8
+ Other Non-current Financial Assets1,656.5754.72,347.6
Non-current Financial Assets2,347.6
+ Deferred Tax Assets15.915.026.0
+ Other Non-current Assets1.03.91.1
Total Non-current Assets1,947.71,152.22,731.2
Current Assets
+ Inventories619.6882.0947.3
+ Trade Receivables319.1380.2361.7
+ Cash & Cash Equivalents291.7560.6442.3
+ Other Bank Balances1,842.81,067.31,812.6
+ Other Current Financial Assets94.61,781.8131.2
Current Financial Assets2,548.23,790.02,747.8
+ Other Current Assets78.169.675.6
Total Current Assets3,245.84,765.13,770.7
Total Assets5,193.55,917.36,501.9
Equity
+ Equity Share Capital21.321.321.3
+ Other Equity / Reserves3,677.64,211.94,752.9
Equity — Owners of Parent3,698.94,233.24,774.2
Total Equity3,698.94,233.24,774.2
Liabilities
+ Provisions — Non-current115.1119.2117.5
Non-current Liabilities151.9277.0251.2
+ Trade Payables18.01,082.3
+ Other Current Financial Liab74.980.988.6
+ Provisions — Current136.8168.0200.9
+ Current Tax Liabilities11.519.713.0
+ Other Current Liabilities70.541.928.8
Current Liabilities1,342.71,407.21,476.6
Total Liabilities1,494.61,684.21,727.7
Total Equity & Liabilities5,193.55,917.36,501.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.